Skip to main content
Log in

Molecular modeling and QSAR analysis of some 4,5-dichloroimidazolyl-1,4-DHP-based calcium channel blockers

  • Article
  • Published:
Journal of the Iranian Chemical Society Aims and scope Submit manuscript

Abstract

The effects of the structural features of some 4,5-dichloroimidazolyl-1,4-dihydropyridine on their calcium channel antagonist activity have been studied using molecular modeling and quantitative structure activity-relationship analysis. Both symmetrical and asymmetrical dihydropyridine derivatives were used. AM1 semi-empirical quantum chemical calculation was used to find the optimum 3-D geometry of the molecules. Four different sets of descriptors, including chemical, topological, quantum chemical and substituent constant, were then calculated for each molecule. For each set of descriptors, the best multilinear QSAR equations were obtained by the stepwise variable selection method using leave-one-out cross-validation as selection criterion. Separate QSAR models were first obtained for symmetrical and asymmetrical derivatives, after which a general model was proposed for the entire set of molecules. This model has root mean square error of 0.45 and reproduces more than 82% of the variances in the calcium channel antagonist activity data. The sum of the negative charges, the energy of the highest occupied molecular orbital, molecular volume and the least negative charge were identified as the most significant descriptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. H. Uneyama, H. Uchida, T. Konda, R. Yoshimoto, N. Akaike, Eur. J. Pharmacol. 373 (1999) 93.

    CAS  Google Scholar 

  2. K.J. Schleifer, J. Med. Chem. 42 (1999) 2204.

    CAS  Google Scholar 

  3. N. Morel, V. Buryi, O. Feron, J.P. Gomez, M.O. Christen, T. Godfraind, Br. J. Pharmacol. 125 (1998) 1005.

    CAS  Google Scholar 

  4. T. Goodfraind, R. Miller, M. Wibo, Pharmacol. Rev. 38 (1986) 321.

    Google Scholar 

  5. P. Belleman, Innovative Approaches in Drug Reseach, Elsevier, Amsterdam, 1986, pp. 23–46.

    Google Scholar 

  6. D.J. Triggle, J. Cardiovasc. Pharmacol. 18 (1991) S1.

    CAS  Google Scholar 

  7. D.A. Langs, Y.W. Kwon, P.D. Strong, D.J. Triggle, J. Comput.-Aid. Mol. Des. 5 (1991) 95.

    CAS  Google Scholar 

  8. H.D. Holtje, Quant. Struct.-Act. Relat. 11 (1992) 224.

    Google Scholar 

  9. N. Iqbal, C.R. Triggle, E.E. Knaus, Drug Dev. Res. 42 (1997) 120.

    CAS  Google Scholar 

  10. N.R. Natale, M.E. Rogers, R. Staples, D.J. Triggle, A. Rutledge, J. Med. Chem. 42 (1999) 3087.

    CAS  Google Scholar 

  11. R.A. Cobrun, M. Wierzba, M.J. Suto, A.J. Solo, A.M. Triggle, D.J. Triggle, J. Med. Chem. 31 (1988) 2103.

    Google Scholar 

  12. M. Mahmoudian, W.G. Richards, J. Pharm. Pharmacol. 38 (1986) 272.

    CAS  Google Scholar 

  13. M. Mahmoudian, W.G. Richards, J. Sci. I. R. Iran. 1 (1990) 261.

    CAS  Google Scholar 

  14. H.D. Holtje, S. Marrer, Quant. Struct.-Act. Relat. 7 (1988) 174.

    Google Scholar 

  15. V.N. Viswanadhan, G.A. Mueller, S.C. Basak, J.N. Weinstein, J. Chem. Inf. Comput. Sci. 41 (2001) 505.

    CAS  Google Scholar 

  16. K.J. Schleifer, E. Tot, Quant. Struct. Act. Relat. 21 (2002) 239.

    CAS  Google Scholar 

  17. M.C.A. Gaudio, A. Korolkovas, Y. Takahata, J. Pharm. Sci. 83 (1994) 1110.

    CAS  Google Scholar 

  18. M.C.A. Costa, A.S. Gaudio, Y. Takahata, J. Mol. Struct. (Theochem.) 394 (1997) 291.

    CAS  Google Scholar 

  19. Y. Takahata, M.C.A. Costa, A.C. Gaudio, J. Chem. Inf. Comput. Sci. 43 (2003) 540.

    CAS  Google Scholar 

  20. D. Hadjipavlou-Litina, Med. Res. Rev. 18 (1998) 91.

    CAS  Google Scholar 

  21. P. Gramatica, E. Papa, QSAR Comb. Sci. 22 (2003) 374.

    CAS  Google Scholar 

  22. C. Hansch, A. Kurup, R. Garg, H. Gao, Chem. Rev. 101 (2001) 619.

    CAS  Google Scholar 

  23. M.A. Safarpour, B. Hemmateenejad, R. Miri, M. Jamali, QSAR Comb. Sci. 22 (2003) 997.

    Google Scholar 

  24. R. Miri, C.A. McEwen, E.E. Knaus, Drug Dev. Res. 51 (2000) 177.

    Google Scholar 

  25. R. Miri, S.E. Howlett, E.E. Knaus, Arch. Pharm. Pharm. Med. Chem. 330 (1997) 290.

    CAS  Google Scholar 

  26. A. Shafiee, R. Miri, A.R. Dehpour, F. Solimani, Pharmaceut. Sci. 2 (1996) 541.

    CAS  Google Scholar 

  27. R. Miri, A.R. Dehpour, M. Azimi, A. Shafiee, Daru 9 (2001) 40.

    CAS  Google Scholar 

  28. R. Miri, H. Niknahad, Gh. Vesal, A. Shafiee, Il Farmaco. 27 (2002) 123.

    Google Scholar 

  29. B. Hemmateenejad, R. Miri, M. Akhond, M. Shamsipur, Arch. Pharm. Pharm. Med. Chem. 10 (2002) 472.

    Google Scholar 

  30. B. Hemmateenejad, R. Miri, M. Akhond, M. Shamsipur, chemometr. Intell. Lab.Syst. 64 (2002) 91.

    CAS  Google Scholar 

  31. B. Hemmateenejad, M. Akhond, R. Miri, M. Shamsipur, J. Chem. Inf. Comput. Sci. 43 (2003) 1328.

    CAS  Google Scholar 

  32. B. Hemmatinejad, R. Miri, M.A. Safarpour, M. Khoshneviszadeh, N. Edraki, J. Mol. Struct. (Theochem.) 717 (2005) 139.

    Google Scholar 

  33. M. Amini, A.A. Golabchifar, A.R. Dehpour, M. Pirali, A. Shafiee, Arznelm. Forsch./Drug Res. 52 (2002) 21.

    CAS  Google Scholar 

  34. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, V.G. Zakrzewski, J.A. Montgomery Jr., R.E. Stratmann, J.C. Burant, S. Dapprich, J.M. Millam, A.D. Daniels, K.N. Kudin, M.C. Strain, O. Farkas, J. Tomasi, V. Barone, M. Cossi, R. Cammi, B. Mennucci, C. Pomelli, C. Adamo, S. Clifford, J. Ochterski, G.A. Petersson, P.Y. Ayala, Q. Cui, K. Morokuma, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J. Cioslowski, J.V. Ortiz, A.G. Baboul, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. Gomperts, R.L. Martin, D.J. Fox, T. Keith, M.A. Al-Laham, C.Y. Peng, A. Nanayakkara, C. Gonzalez, M. Challacombe, P.M.W. Gill, B. Johnson, W. Chen, M.W. Wong, J.L. Andres, C. Gonzalez, M. Head-Gordon, E.S. Replogle, J.A. Pople, Gaussian 98, Revision A.7, Gaussian, Inc., Pittsburgh PA, 1998.

    Google Scholar 

  35. S. Eric, T. Solmajer, J. Zupan, M. Novic, M. Oblak, D. Agbaba, J. Mol. Model. 10 (2004) 139.

    CAS  Google Scholar 

  36. R. Todeschini, Milano Chemometrics and QSAR Group, http://www.disat.unimib.it/vhm/.

  37. S. Goldmann, J. Stoltefuss, Angew. Chem., Int. Ed. Engl. 30 (1991) 1559.

    Google Scholar 

  38. G. Rovayak, N. Anderson, J. Gougoutas, A. Hedberg, S.D. Kimball, M. Malley, S. Moreland, M. Porubcan, A. Pudzianowski, J. Med. Chem. 31 (1988) 936.

    Google Scholar 

  39. D.A. Langs, D.J. Triggle, Mol. Pharmacol. 27 (1985) 936.

    Google Scholar 

  40. E. Gaggelli, N. Marchettini, G. Valensin, J. Chem. Soc. Perkin Trans. 2 (1987) 1707.

    Google Scholar 

  41. S. Goldmann, J. Stoltefuss, Angew. Chem. 130 (1991) 1587.

    Google Scholar 

  42. M. Tucbilek, S. Ozbey, E. Kendi, E. Yildirim, K. Erol, R. Ertan, Il Farmaco 54 (1999) 660.

    Google Scholar 

  43. R.B. Palmar, N.H. Andersen, Bioorg, Med. Chem. Lett. 6 (1996) 2173.

    Google Scholar 

  44. C. Rovnyak, S.D. Kimbal, B. Beyer, G. Cucinotta, J.D. Dimarco, J. Gougoutas, A. Hedberg, M. Malley, J.P. McCarthy., R. Zhang, S. Moreland, J. Med. Chem. 38 (1995) 119.

    CAS  Google Scholar 

  45. M.C. Ramusino, M.R. Vari, J. Mol. Struct. (Theochem.) 492 (1999) 257.

    Google Scholar 

  46. B. Hemmateenejad, J. Chemometr. 18 (2004) 475.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Hemmateenejad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hemmateenejad, B., Miri, R., Edraki, N. et al. Molecular modeling and QSAR analysis of some 4,5-dichloroimidazolyl-1,4-DHP-based calcium channel blockers. JICS 4, 182–193 (2007). https://doi.org/10.1007/BF03245965

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03245965

Keywords

Navigation